Company
NEXGEL
NASDAQ:NXGL
NEXGEL, Inc. is an FDA registered and ISO certified facility, and our hydrogel platform technology can be manufactured with or without active ingredients. Whether our gentle patch is used for OTC medications, wound healing and care, or cosmetics and commercial product applications, we pride ourselves in our flexibility, versatility and superior consumer experience.
14 stories
NEXGEL says Q3 revenue jumps almost 70%
“We expect to grow revenue in 2023 and margins to expand as we continue to scale while realizing the benefits from our fixed facility expense structure,” said CEO Adam Levy
NEXGEL studies diclofenac hydrogel patches as new pain medication delivery method
NEXGEL's patches delivered an equivalent dose faster and are longer-acting compared to the current standard-of-care for short term pain treatment
NEXGEL develops hydrogel patch to treat lazy eye; works better for younger children
The patch will be available to ophthalmologists and optometrists in first half of 2023